First-dose response partially predicts the first-year anti-VEGF response in PCV patients: A post-hoc analysis of START Trial.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2023)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要